Fresh from a European cancer conference that was all about antibody-drug conjugates (ADCs), GSK has turned to French biotech ...

GSK acquires exclusive rights from Syndivia for an ADC targeting advanced prostate cancer in a deal up to £268 m, reinforcing ...

GSK plc GSK reported third-quarter 2025 core earnings of $1.48 per American depositary share (ADS), which beat the Zacks Consensus Estimate of $1.26. Core earnings increased 11% year over year on a ...

Q3 2025 Earnings Call Transcript October 29, 2025 GSK plc beats earnings expectations. Reported EPS is $1.48, expectations ...

GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia in a ...

Despite news that GlaxoSmithKline ($GSK) is dumping a satellite R&D facility in France and cutting 70 positions, the pharma giant says it will grow its manufacturing ...

DIJON, France--(BUSINESS WIRE)--Regulatory News: GSK and Oncodesign (Paris:ALONC) have signed an agreement for Oncodesign to acquire the François Hyafil Research Centre located in Villebon-sur-Yvette ...

Late last year GlaxoSmithKline ($GSK) set its sights on reorganizing and downsizing its R&D group, laying off hundreds of staffers in North Carolina as it ...

According to sources, MRM has resigned Marie France and GlaxoSmithKline. At the same time, the agency is restructuring its Shanghai and Beijing offices, centralising its resources in Beijing as it ...

British pharmaceutical giant GSK on Monday said longtime chief executive Emma Walmsley will be replaced by its chief ...

British pharmaceutical group GSK on Wednesday raised its full-year outlook after strong sales growth in its third quarter, ...